Stereotactic Body Radiotherapy for Large Unresectable Hepatocellular Carcinomas - A Single Institution Phase II Study.

L Beaton, E M Dunne,R Yeung, T Rackley,B Weber, C Mar,C J Yong-Hing, E M Yoshida, K DeVries,R Lee, C Duzenli, S K Loewen,M Liu,D Schellenberg,R Ma

Clinical Oncology（2020）

引用 15|浏览47

暂无评分

摘要

•SBRT is a safe and effective treatment for large unresectable HCCs >5 cm.•SBRT can be delivered safely even after previous liver-directed therapies.•SBRT provides excellent local control with control rates of 92% at 1 year.•SBRT for large unresectable HCCs provides a median overall surviva1 of 17.7 months.

查看译文

关键词

Hepatocellular carcinoma,stereotactic body radiotherapy (SBRT),unresectable

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要